{"transactions":[{"id":3010337,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":146060,"kind":"person","name":"MORRIS I WISTAR III","position":1,"cik":"0000898242","reported_name":"MORRIS I WISTAR III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2020-10-08T18:14:36.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":111111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Series A Convertible Preferred Stock underlying this warrant automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":111111,"derivative":{"exercise_price":9,"expiration_date":"2023-06-02","underlying":"Common Stock","underlying_shares":111111},"source":{"system":"sec-edgar","filing":"0001209191-20-054317","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/898242/000120919120054317/doc4.xml","form_type":"4"}},{"id":3010336,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":146060,"kind":"person","name":"MORRIS I WISTAR III","position":1,"cik":"0000898242","reported_name":"MORRIS I WISTAR III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2020-10-08T18:14:36.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":111111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each share of Series A Convertible Preferred Stock underlying this warrant automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":9,"expiration_date":"2023-06-02","underlying":"Series A Convertible Preferred Stock","underlying_shares":111111},"source":{"system":"sec-edgar","filing":"0001209191-20-054317","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/898242/000120919120054317/doc4.xml","form_type":"4"}},{"id":3010335,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":146060,"kind":"person","name":"MORRIS I WISTAR III","position":1,"cik":"0000898242","reported_name":"MORRIS I WISTAR III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-10-08T18:14:36.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":38464,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Cotswold Foundation (the \"Foundation\"). the Reporting Person has voting and investment power with respect to shares held by the Foundation."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":38464},"source":{"system":"sec-edgar","filing":"0001209191-20-054317","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/898242/000120919120054317/doc4.xml","form_type":"4"}},{"id":3010334,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":146060,"kind":"person","name":"MORRIS I WISTAR III","position":1,"cik":"0000898242","reported_name":"MORRIS I WISTAR III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-10-08T18:14:36.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":882475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":882475},"source":{"system":"sec-edgar","filing":"0001209191-20-054317","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/898242/000120919120054317/doc4.xml","form_type":"4"}},{"id":3010333,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":146060,"kind":"person","name":"MORRIS I WISTAR III","position":1,"cik":"0000898242","reported_name":"MORRIS I WISTAR III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-08T18:14:36.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":38464,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Cotswold Foundation (the \"Foundation\"). the Reporting Person has voting and investment power with respect to shares held by the Foundation."}],"balance_after":38464,"source":{"system":"sec-edgar","filing":"0001209191-20-054317","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898242/000120919120054317/doc4.xml","form_type":"4"}},{"id":3010332,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":146060,"kind":"person","name":"MORRIS I WISTAR III","position":1,"cik":"0000898242","reported_name":"MORRIS I WISTAR III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-08T18:14:36.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":882475,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the\nIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date."}],"balance_after":882475,"source":{"system":"sec-edgar","filing":"0001209191-20-054317","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898242/000120919120054317/doc4.xml","form_type":"4"}}]}